CN1600326A - 一种治疗小脑萎缩的药物 - Google Patents
一种治疗小脑萎缩的药物 Download PDFInfo
- Publication number
- CN1600326A CN1600326A CN 03126381 CN03126381A CN1600326A CN 1600326 A CN1600326 A CN 1600326A CN 03126381 CN03126381 CN 03126381 CN 03126381 A CN03126381 A CN 03126381A CN 1600326 A CN1600326 A CN 1600326A
- Authority
- CN
- China
- Prior art keywords
- grams
- gram
- radix
- medicine
- cerebellar atrophy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 37
- 206010003694 Atrophy Diseases 0.000 title abstract description 3
- 230000037444 atrophy Effects 0.000 title abstract description 3
- 229940079593 drug Drugs 0.000 title description 15
- 210000001638 cerebellum Anatomy 0.000 title 1
- 206010008027 Cerebellar atrophy Diseases 0.000 claims abstract description 14
- 239000000463 material Substances 0.000 claims abstract description 5
- 241000756943 Codonopsis Species 0.000 claims description 11
- 239000009636 Huang Qi Substances 0.000 claims description 11
- 241000190633 Cordyceps Species 0.000 claims description 10
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000007788 liquid Substances 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 241000675108 Citrus tangerina Species 0.000 abstract 1
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 abstract 1
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 abstract 1
- 229940107666 astragalus root Drugs 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 10
- 235000019634 flavors Nutrition 0.000 description 10
- 239000000203 mixture Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 7
- 239000008280 blood Substances 0.000 description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 6
- 210000000952 spleen Anatomy 0.000 description 6
- 241000721047 Danaus plexippus Species 0.000 description 5
- 210000004369 blood Anatomy 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 230000036407 pain Effects 0.000 description 4
- 239000000341 volatile oil Substances 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 238000003672 processing method Methods 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TYPSVDGIQAOBAD-DZGCQCFKSA-N Atractylone Chemical compound C([C@]1(C)C2)CCC(=C)[C@@H]1CC1=C2OC=C1C TYPSVDGIQAOBAD-DZGCQCFKSA-N 0.000 description 2
- 208000002381 Brain Hypoxia Diseases 0.000 description 2
- 208000024806 Brain atrophy Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- 208000004929 Facial Paralysis Diseases 0.000 description 2
- 208000004547 Hallucinations Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 206010033799 Paralysis Diseases 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 208000036826 VIIth nerve paralysis Diseases 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 206010016256 fatigue Diseases 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- YNWXJFQOCHMPCK-LXGDFETPSA-N isoliquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C=C1)=CC=C1\C=C\C(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-LXGDFETPSA-N 0.000 description 2
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 229930182490 saponin Natural products 0.000 description 2
- 150000007949 saponins Chemical class 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- GSZUGBAEBARHAW-UHFFFAOYSA-N sophoraflavone B Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C=2OC3=CC(O)=CC=C3C(=O)C=2)C=C1 GSZUGBAEBARHAW-UHFFFAOYSA-N 0.000 description 2
- 230000002269 spontaneous effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- ULSUXBXHSYSGDT-UHFFFAOYSA-N tangeretin Chemical compound C1=CC(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 ULSUXBXHSYSGDT-UHFFFAOYSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 230000008673 vomiting Effects 0.000 description 2
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 description 1
- AAWZDTNXLSGCEK-LNVDRNJUSA-N (3r,5r)-1,3,4,5-tetrahydroxycyclohexane-1-carboxylic acid Chemical class O[C@@H]1CC(O)(C(O)=O)C[C@@H](O)C1O AAWZDTNXLSGCEK-LNVDRNJUSA-N 0.000 description 1
- 125000000545 (4R)-limonene group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- KSDSYIXRWHRPMN-UHFFFAOYSA-N 4'-O-beta-D-Galactopyranoside-6''-p-Coumaroylprunin-4',5,7-Trihydroxyflavanone Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC(O)=C3C(=O)C2)C=C1 KSDSYIXRWHRPMN-UHFFFAOYSA-N 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 244000061520 Angelica archangelica Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- DHHFDKNIEVKVKS-FMOSSLLZSA-N Betanin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC(C(=C1)O)=CC(C[C@H]2C([O-])=O)=C1[N+]2=C\C=C\1C=C(C(O)=O)N[C@H](C(O)=O)C/1 DHHFDKNIEVKVKS-FMOSSLLZSA-N 0.000 description 1
- DHHFDKNIEVKVKS-MVUYWVKGSA-N Betanin Natural products O=C(O)[C@@H]1NC(C(=O)O)=C/C(=C\C=[N+]/2\[C@@H](C(=O)[O-])Cc3c\2cc(O)c(O[C@H]2[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O2)c3)/C1 DHHFDKNIEVKVKS-MVUYWVKGSA-N 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000208671 Campanulaceae Species 0.000 description 1
- 206010065559 Cerebral arteriosclerosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- JZVFJDZBLUFKCA-ZXLWUMLCSA-N Chondrillasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-ZXLWUMLCSA-N 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 244000192528 Chrysanthemum parthenium Species 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241001480006 Clavicipitaceae Species 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- XMGQYMWWDOXHJM-JTQLQIEISA-N D-limonene Natural products CC(=C)[C@@H]1CCC(C)=CC1 XMGQYMWWDOXHJM-JTQLQIEISA-N 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- 206010013886 Dysaesthesia Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010063006 Facial spasm Diseases 0.000 description 1
- 239000004378 Glycyrrhizin Substances 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000004044 Hypesthesia Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- YNWXJFQOCHMPCK-UHFFFAOYSA-N Isoliquiritin Natural products OC1C(O)C(O)C(CO)OC1OC(C=C1)=CC=C1C=CC(=O)C1=CC=C(O)C=C1O YNWXJFQOCHMPCK-UHFFFAOYSA-N 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- FURUXTVZLHCCNA-UHFFFAOYSA-N Liquiritigenin Natural products C1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-UHFFFAOYSA-N 0.000 description 1
- DEMKZLAVQYISIA-ONJCETCRSA-N Liquiritin Natural products O([C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)c1ccc([C@@H]2Oc3c(C(=O)C2)ccc(O)c3)cc1 DEMKZLAVQYISIA-ONJCETCRSA-N 0.000 description 1
- DEMKZLAVQYISIA-UHFFFAOYSA-N Liquirtin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(C2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000001089 Multiple system atrophy Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- OBIOZWXPDBWYHB-UHFFFAOYSA-N Nobiletin Natural products C1=CC(OC)=CC=C1C1=C(OC)C(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 OBIOZWXPDBWYHB-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 206010034719 Personality change Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- JZVFJDZBLUFKCA-INYURWPISA-N Poriferasta-7,22E-dien-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)/C=C/[C@H](CC)C(C)C)CC[C@H]33)C)C3=CC[C@H]21 JZVFJDZBLUFKCA-INYURWPISA-N 0.000 description 1
- 206010057071 Rectal tenesmus Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 208000008630 Sialorrhea Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- IECRXMSGDFIOEY-UHFFFAOYSA-N Tangeretin Natural products COC=1C(OC)=C(OC)C(OC)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 IECRXMSGDFIOEY-UHFFFAOYSA-N 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- JZVFJDZBLUFKCA-UTQQLQBSSA-N alpha-spinasterol Natural products CC[C@H](C=C[C@H](C)[C@H]1CC[C@H]2C3=CC[C@@H]4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C JZVFJDZBLUFKCA-UTQQLQBSSA-N 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001430 anti-depressive effect Effects 0.000 description 1
- 239000000935 antidepressant agent Substances 0.000 description 1
- 201000007201 aphasia Diseases 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- TYPSVDGIQAOBAD-UHFFFAOYSA-N atractylone Natural products C1C2(C)CCCC(=C)C2CC2=C1OC=C2C TYPSVDGIQAOBAD-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 description 1
- 235000012677 beetroot red Nutrition 0.000 description 1
- 239000001654 beetroot red Substances 0.000 description 1
- 235000002185 betanin Nutrition 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 230000001149 cognitive effect Effects 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 231100000895 deafness Toxicity 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003414 extremity Anatomy 0.000 description 1
- 210000001097 facial muscle Anatomy 0.000 description 1
- 208000014337 facial nerve disease Diseases 0.000 description 1
- 239000010685 fatty oil Substances 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- -1 flavone compound Chemical class 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000016354 hearing loss disease Diseases 0.000 description 1
- 229940025878 hesperidin Drugs 0.000 description 1
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 1
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 208000034783 hypoesthesia Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 201000005851 intracranial arteriosclerosis Diseases 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- JBQATDIMBVLPRB-UHFFFAOYSA-N isoliquiritigenin Natural products OC1=CC(O)=CC=C1C1OC2=CC(O)=CC=C2C(=O)C1 JBQATDIMBVLPRB-UHFFFAOYSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- FURUXTVZLHCCNA-AWEZNQCLSA-N liquiritigenin Chemical compound C1=CC(O)=CC=C1[C@H]1OC2=CC(O)=CC=C2C(=O)C1 FURUXTVZLHCCNA-AWEZNQCLSA-N 0.000 description 1
- DEMKZLAVQYISIA-ZRWXNEIDSA-N liquiritin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C([C@H]2OC3=CC(O)=CC=C3C(=O)C2)C=C1 DEMKZLAVQYISIA-ZRWXNEIDSA-N 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- ARGKVCXINMKCAZ-UZRWAPQLSA-N neohesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O[C@H]3[C@@H]([C@H](O)[C@@H](O)[C@H](C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UZRWAPQLSA-N 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- MRIAQLRQZPPODS-UHFFFAOYSA-N nobiletin Chemical compound C1=C(OC)C(OC)=CC=C1C1=CC(=O)C2=C(OC)C(OC)=C(OC)C(OC)=C2O1 MRIAQLRQZPPODS-UHFFFAOYSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 208000031237 olivopontocerebellar atrophy Diseases 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 208000035824 paresthesia Diseases 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 208000037821 progressive disease Diseases 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000001932 seasonal effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 210000000278 spinal cord Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 208000012271 tenesmus Diseases 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开一种治疗小脑萎缩的药物，它是由下列重量配比的原料制成的药剂：当归3－10克、党参10－15克、黄芪10一15克、冬虫夏草3－10克、白术3－10克、升麻3－10克，柴胡3－10克、陈皮3－10克、甘草1.5－10克。探索脑萎缩的发病机理，治疗小脑萎缩应以补肾填精、通气血为原则。根据以上原则，结合当归、党参、黄芪、冬虫夏草等中药的药理作用，经过精心配制，采用君、臣、佐、使的配伍原则制成了本发明治疗小脑萎缩的药物。该药物对脊髓有选择性兴奋作用，对大脑皮层亦有一定兴奋作用，主要作用于中枢神经系统，能兴奋神经，增加抵抗力，免疫力，对中气下行神经衰弱的表现，能提高疗效，能克服其它兴奋剂的痹病，本品常用有保健，长寿的作用，特别是小脑萎缩，橄榄桥萎缩，能起到治疗的效果，消除一切症状，恢复健康。本发明的药物经80例临床统计结果如下：有效75例、治愈50例、无效5例，总有效率达93.7％，治愈率达62.5％。
Description
技术领域
本发明涉及一种治疗脑部疾病的药物，尤其是一种治疗小脑萎缩的药物。
背景技术
脑萎缩疾病是医学界公认的一种疑难顽症，很难治愈。小脑萎缩是一种脑部供血不足，脑缺氧，细胞相对减少而引起的神经功能失调的慢性进行性疾病，轻者记忆力减退，定向失常，视力、听力下降，个性改变，自私、多疑，对人冷漠，重者出现语无伦次，认知模糊，幻听幻觉，大小便失禁，供济失调，脑动脉硬化及脑外伤等，甚至终身瘫痪。脑梗塞、脑萎缩的主要症状：面容痴呆、言语不清或失语、肢体疼痛不会走路、有的面肌痉挛(抽搐)面肌僵硬、萎缩、面神经麻痹、面神经炎、中风面瘫(口眼歪邪、流口水)甚至终身瘫痪。目前国内还没有有效的治疗药物。
发明内容
本发明的目的是提供一种治疗小脑萎缩的药物。
本发明的技术方案是：一种治疗小脑萎缩的药物，它是由下列重量配比的原料制成的药剂：当归3-10克、党参10-15克、黄芪10-15克、冬虫夏草3-10克、白术3-10克、升麻3-10克，柴胡3-10克、陈皮3-10克、甘草1.5-10克。
它是由下列重量配比的原料制成的药剂：当归6克、党参12克、黄芪12克、冬虫夏草5克、白术7克、升麻5克，柴胡6克、陈皮4克、甘草3克。
所述的药剂为口服液、丸剂或针剂。
小脑萎缩致病因素原因很多，归属于肾，引起肾经亏耗的原因有如下多方面：自然消耗、先天失调、情志内伤、饮食和饥饱失常、邪毒伤害、病后失养、七情忧郁过度、劳伤过度、房事过多、六淫伤害、睡眠不足、烟酒过量、遗传所致。
探索脑萎缩的发病机理，治疗小脑萎缩应以补肾填精、通气血为原则。根据以上原则，结合当归、党参、黄芪、冬虫夏草等中药的药理作用，经过精心配制，采用君、臣、佐、使的配伍原则制成了本发明治疗小脑萎缩的药物。该药物对脊髓有选择性兴奋作用，对大脑皮层亦有一定兴奋作用，主要作用于中枢神经系统，能兴奋神经，增加抵抗力，免疫力，对中气下行神经衰弱的表现，能提高疗效，能克服其它兴奋剂的痹病，本品常用有保健，长寿的作用，特别是小脑萎缩，橄榄桥萎缩，能起到治疗的效果，消除一切症状，恢复健康。本发明的药物经80例临床统计结果如下：有效75例、治愈50例、无效5例，总有效率达93.7％，治愈率达62.5％。
注意事项：治疗小脑萎缩的药物由于它是以治本为主，能增加抵抗力，提高免疫力，一般无禁忌症，若有临时感冒等发烧病人暂停用药或减量。
本发明的药物组分：
以当归、党参、黄芪、冬虫夏草为君，白术、升麻为臣，其余几味为佐使。
当归：本品为伞形科植物当归的根。
成份：含挥发油、棕榈酸、蔗糖、维生素B12、烟酸、维生素E等。
性味：甘、辛、温。
功能：补血活血、化瘀生新、调经润燥。
主治：血虚头痛、腰痛、心腹诸痛、大便燥结、痿痹、症瘕痈疽疮疡、经闭、经来腹痛、崩漏。
用量：3——10克。
黄芪：本品为豆科植内蒙黄芪，其膜黄芪的根。
成份：含胆碱、甜菜碱、叶酸、氨基酸、糖类等。
性味：甘、微温。
功能：补气固表、托毒生肌。
主治：表虚自汗、盗汗、气虚血脱、脾虚泻泄、痈疽不溃或溃不收敛，及一切元气不足之症。
用量：10——15克。
党参：本品为桔梗科植物党参的根。
成份：含糖及皂甙。
性味：甘、平。
功能：补中、益气、生津。
主治：脾胃虚弱、体倦无力、肺虚咳嗽、口渴、少食。
用量：10——15克。
甘草：本品为豆科植物甘草的根及根茎。
成份：含甘草甜素、甘草甙、甘草甙元、异甘草甙、异甘草甙元、新甘草甙、新甘草甙元、甘露醇B-固甾醇、糖类、有机酸等。
性味：甘、平。
功能：补脾胃、益气、润肺止咳、清热解毒、调合诸药。
主治：脾胃虚弱、咳嗽、心悸、痈疽肿毒、小儿胎毒、咽喉肿痛、疮疡、中毒。
用量：1.5——10克。
白术：本品为菊科植物白术的根茎。
成份：含挥发油，主要为苍术醇、苍术酮、维生素A等。
性味：甘、苦、温。
功能：补脾、燥湿、和中。
主治：脾虚劳倦、食少泄泻、水肿、自汗、胎动不安、脘腹虚胀等。
用量：3——10克。
升麻：成份：含生物碱、皂甙、挥发油。
性味：甘、平、微苦、寒。
功能：升阳散风、解毒透疗。
主治：时气疫疠、阳明头痛、喉痛、斑疹风热疮疡，中气下陷，久泄脱肛。
用量：3——10克。
柴胡：成份：主要含有柴胡皂甙、菠菜甾醇、脂肪油、木蜡酸及挥发油等。
性味：苦微寒。
功能：发表和里、升阳解郁。
主治：寒热往来、胸满胁痛、口苦、呕吐、头眩、耳聋、疟疾、中气下陷、脱肛、月经不调、子宫下坠。
用量：3——10克。
陈皮：成份：含挥发油2-4％，油中主要成份为d-柠檬烯和构木醛等，另含黄酮类化合物：橙皮甙、新橙皮甙、桔皮素、川陈皮素、2氢川陈皮素等，此外有肌醇，维生素B、C等。
性味：苦、辛、温。
功能：理气燥湿、导滞消痰。
主治：胸腹胀满、呕吐泻泄、咳嗽多痰。
用量：3——10克。
冬虫夏草：本品为麦角菌科植物。
成份：含蛋白质、虫草酸、系奎尼酸异构体。此外还含冬虫夏草菌素。
性味：甘、温。
功能：滋肺补肾、填精益气、止血、化痰。
主治：虚劳咳血、阳痿遗精、腰膝酸痛。
用量：3——10克。
具体实施方式
实施例1：选用当归3克、党参10克、黄芪10克、冬虫夏草3克为君药，白术3克、升麻3克为臣药，柴胡3克、陈皮3克、甘草1.5克为佐使，按照中药配伍原则及常用炮制和加工方法制成中药蜜丸或口服液或针剂。
实施例2：选用当归6克、党参12克、黄芪12克、冬虫夏草5克为君药，白术7克、升麻5克为臣药，柴胡6克、陈皮4克、甘草3克为佐使，按照中药配伍原则及常用炮制和加工方法制成中药蜜丸或口服液或针剂。
实施例3：选用当归10克、党参15克、黄芪15克、冬虫夏草10克为君药，白术10克、升麻10克为臣药，柴胡10克、陈皮10克、甘草10克为佐使，按照中药配伍原则及常用炮制和加工方法制成中药蜜丸或口服液或针剂。
Claims (3)
1、一种治疗小脑萎缩的药物，其特征是：它是由下列重量配比的原料制成的药剂：当归3-10克、党参10-15克、黄芪10-15克、冬虫夏草3-10克、白术3-10克、升麻3-10克，柴胡3-10克、陈皮3-10克、甘草1.5-10克。
2、根据权利要求1所述的治疗小脑萎缩的药物，其特征是：它是由下列重量配比的原料制成的药剂：当归6克、党参12克、黄芪12克、冬虫夏草5克、白术7克、升麻5克，柴胡6克、陈皮4克、甘草3克。
3、根据权利要求1或2所述的治疗小脑萎缩的药物，其特征是：所述的药剂为口服液、丸剂或针剂。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126381 CN1600326A (zh) | 2003-09-24 | 2003-09-24 | 一种治疗小脑萎缩的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 03126381 CN1600326A (zh) | 2003-09-24 | 2003-09-24 | 一种治疗小脑萎缩的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1600326A true CN1600326A (zh) | 2005-03-30 |
Family
ID=34658778
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 03126381 Pending CN1600326A (zh) | 2003-09-24 | 2003-09-24 | 一种治疗小脑萎缩的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1600326A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102133290A (zh) * | 2011-03-16 | 2011-07-27 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 补中益气丸在电磁辐射防护中的用途 |
| CN104367957A (zh) * | 2014-11-21 | 2015-02-25 | 郝建国 | 小脑发育不全补髓益智制剂及制法 |
| CN113209283A (zh) * | 2021-06-03 | 2021-08-06 | 绵阳德康疼痛医院 | 一种神经康复散及其制备和使用方法 |
-
2003
- 2003-09-24 CN CN 03126381 patent/CN1600326A/zh active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102133290A (zh) * | 2011-03-16 | 2011-07-27 | 中国人民解放军军事医学科学院放射与辐射医学研究所 | 补中益气丸在电磁辐射防护中的用途 |
| CN104367957A (zh) * | 2014-11-21 | 2015-02-25 | 郝建国 | 小脑发育不全补髓益智制剂及制法 |
| CN113209283A (zh) * | 2021-06-03 | 2021-08-06 | 绵阳德康疼痛医院 | 一种神经康复散及其制备和使用方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101053632A (zh) | 一种治疗血栓闭塞性脉管炎的中药 | |
| CN1857666A (zh) | 一种治疗老年期痴呆的中药制剂 | |
| CN101041033A (zh) | 一种治疗乙肝的中药 | |
| CN1419927A (zh) | 中医药辨证治疗肾炎、肾病综合症的系列方案及中药制剂 | |
| CN101057942A (zh) | 一种治疗糖尿病足的外用药膏及其制备方法 | |
| CN104474104A (zh) | 一种防治鸡传染性鼻炎的中药组合物及其制备方法 | |
| CN1686502A (zh) | 增强人体免疫功能的药物 | |
| CN1254254C (zh) | 一种用于治疗鼻渊的中成药 | |
| CN1600326A (zh) | 一种治疗小脑萎缩的药物 | |
| CN1318378A (zh) | 治疗热症的中成药 | |
| CN107412640A (zh) | 一种用于辅助针灸理疗的外用药膏 | |
| CN1202855C (zh) | 用于治疗耳聋、耳鸣的中药及其制备方法 | |
| CN1410105A (zh) | 紫贝止咳颗粒及制备方法 | |
| CN1682895A (zh) | 一种定喘止咳的药物及其制备方法 | |
| CN1931262A (zh) | 一种治疗感冒的中药制剂 | |
| CN1915400A (zh) | 治疗鼻渊病症的药物 | |
| CN1256976C (zh) | 一种抗癌中药组合物及其制备方法 | |
| CN1259953C (zh) | 一种抗衰老保健药物 | |
| CN1857533A (zh) | 一种预防和治疗脑血栓及后遗症的中药制剂 | |
| CN102671052B (zh) | 治疗美尼尔氏综合症的中药组合物 | |
| CN1115160C (zh) | 治疗骨质增生的口服药物 | |
| CN1299748C (zh) | 一种减肥调理补气袋 | |
| CN101041002A (zh) | 一种内服治疗鼻窦炎的中药组合物 | |
| CN1253195C (zh) | 一种抗衰老中药胶囊及其制法 | |
| CN1528430A (zh) | 治疗冠心病、病毒性心肌炎的中药制剂 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |